Mirion Technologies (MIR) Announces Proposed 7M Share Offering

Mirion Technologies, Inc. (NYSE: MIR) today announced the commencement of an underwritten public offering of 7,000,000 shares of Mirion’s Class A common stock by certain selling stockholders. Selling stockholders participating in the offering consist of entities affiliated with Charterhouse Capital Partners. Mirion will not sell any securities in the proposed offering and will not receive any of the proceeds from the sale of the shares being offered by the selling stockholders, but Mirion will bear the costs associated with the proposed offering, other than underwriting discounts and commissions and certain other expenses. The offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering may be completed or as to the actual size or terms of the offering.

Citigroup is acting as the sole bookrunner for the offering.

The offering will be made pursuant to a shelf registration statement, including a base prospectus, declared effective by the Securities and Exchange Commission (the “SEC”) on November 28, 2022. Before you invest, you should read the prospectus in the registration statement and the other documents Mirion has filed or will file with the SEC for more complete information about Mirion and this offering. The proposed offering is being made only by means of an effective shelf registration statement, including a base prospectus and final prospectus supplement, copies of which may be obtained, when available, free of charge at the SEC’s website at www.sec.gov. When available, copies of the prospectus supplement and accompanying prospectus related to the offering may also be obtained from Citigroup, c/o Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, NY 11717 (Tel: 800-831-9146).

This press release shall not constitute an offer to sell or a solicitation of an offer to buy these securities, nor shall there be any offer or sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of any such state or jurisdiction.

You May Also Be Interested In

• enVVeno Medical (NVNO) files $100M mixed shelf
• Gossamer Bio raises up to $250M in private placement for PAH drug
• Elroy Air wins $46M U.S. Army contract for cargo drone system